IMMUNOMINE Trademark

Trademark Overview

On Thursday, June 27, 2002, a trademark application was filed for IMMUNOMINE with the United States Patent and Trademark Office. The USPTO has given the IMMUNOMINE trademark a serial number of 76428124. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, March 4, 2016. This trademark is owned by Viventia Biotech Inc.. The IMMUNOMINE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Product research and development in the field of recombinant proteins for immunotheraphy
immunomine

General Information

Serial Number76428124
Word MarkIMMUNOMINE
Filing DateThursday, June 27, 2002
Status710 - CANCELLED - SECTION 8
Status DateFriday, March 4, 2016
Registration Number2975078
Registration DateTuesday, July 26, 2005
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 8, 2004

Trademark Statements

Goods and ServicesProduct research and development in the field of recombinant proteins for immunotheraphy

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, March 4, 2016
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameVIVENTIA BIOTECHNOLOGIES INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressMISSISSAUGA, ONTARIO L5S 1V9
CA
Party NameViventia Biotech Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMississauga L4W 5N5
Party NameViventia Biotech Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressToronto, Ontario M9B 6H7
CA
Party NameViventia Biotech Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressToronto, Ontario M9B 6H7
CA

Trademark Events

Event DateEvent Description
Friday, March 4, 2016CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Tuesday, October 4, 2011NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, October 4, 2011REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, October 4, 2011CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, September 19, 2011TEAS SECTION 8 & 15 RECEIVED
Wednesday, August 31, 2011AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, October 24, 2006APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, October 24, 2006TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, July 26, 2005REGISTERED-PRINCIPAL REGISTER
Wednesday, January 12, 20051(B) BASIS DELETED; PROCEED TO REGISTRATION
Wednesday, January 12, 2005NOTICE OF ALLOWANCE CANCELLED
Friday, January 7, 2005FAX RECEIVED
Tuesday, August 31, 2004NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 8, 2004PUBLISHED FOR OPPOSITION
Wednesday, May 19, 2004NOTICE OF PUBLICATION
Thursday, April 1, 2004APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, February 2, 2004CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 2, 2004PAPER RECEIVED
Monday, July 28, 2003LETTER OF SUSPENSION MAILED
Thursday, June 12, 2003CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 26, 2003CASE FILE IN TICRS
Thursday, June 12, 2003PAPER RECEIVED
Monday, December 9, 2002NON-FINAL ACTION MAILED
Thursday, November 14, 2002CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 14, 2002PAPER RECEIVED
Thursday, October 3, 2002NON-FINAL ACTION MAILED
Monday, September 30, 2002ASSIGNED TO EXAMINER
Thursday, September 26, 2002ASSIGNED TO EXAMINER

Related Keywords

immunomine proteins immunotheraphy recombinant field research development product